Ithappenz Morning After Tablet
Product Images NDC 58602-892

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Ithappenz Morning After (NDC 58602-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel -1.5 mg (1 Tablet Carton Label) (Levonorgestrel Fig1)

Package Label-principal Display Panel -1.5 mg (1 Tablet Carton Label) (Levonorgestrel Fig1)
The text describes a morning after emergency contraceptive tablet called Levonorgestrel, which reduces the chance of pregnancy after unprotected sex. The medication should be taken as soon as possible within 72 hours after intercourse. It is not meant for regular birth control. The text also warns against using the medication if you are allergic to Levonorgestrel, and to seek medical advice before use. The image contains a phone number to contact for additional information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.